Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Personalized Medicine Coalition (PMC) – Upcoming Events

Reporter: Aviva Lev-Ari, PhD, RN

About PMC

PMC promotes the advancement of personalized medicine, by addressing regulatory, reimbursement, privacy, ethical, and educational issues critical to the field. Based on the diversity of its membership, PMC has become the preeminent voice shaping policy about and increasing investment in personalized medicine.

The Coalition:

• Provides opinion leadership on public policy issues that affect personalized medicine;

• Helps educate policymakers in government, industry, and academia about the benefits of personalized medicine; and

• Serves as a forum for identifying and informing others of public policies that could advance or impede the development of personalized medicine

EXECUTIVE COMMITTEE

Edward Abrahams, Ph.D.

President

Personalized Medicine Coalition

William S. Dalton, M.D., Ph.D.

(Chair – PMC)

M2Gen/Moffitt Cancer Center

Stephen L. Eck, M.D., Ph.D.

(Vice Chair – PMC)

Astellas Pharma Global

Development

D. Stafford O’Kelly

(Treasurer – PMC)

Abbott Molecular (Ret.)

Amy P. Abernethy, M.D., Ph.D.

(Secretary – PMC)

Duke University Medical Center

J. Brian Munroe

(Past President & Chair – PMC)

Endo Pharmaceuticals

Boar d of Directors

Steven D. Averbuch, M.D.

Bristol-Myers Squibb Company

Patrick J. Balthrop

Luminex Corporation

Paul R. Billings, M.D., Ph.D.

Life Technologies

Jeffrey Cossman, M.D.

United States Diagnostic

Standards (USDS)

Neil de Crescenzo

Emdeon

Donna R Cryer, J.D.

Global Liver Foundation

Felix W. Frueh, Ph.D.

Opus Three, LLC

Tim Garnett, FRCOG, MFFP, FFPM

Eli Lilly and Company

Julie K. Goonewardene

Member, Board of Trustees,

American Medical Association

1710 Rhode Island Ave., NW, Suite 700

Washington, DC 20036

P: 202.589.1770

pmc@personalizedmedicinecoalition.org

Michael Kolodziej, M.D.

Aetna

Lawrence J. Lesko, Ph.D., F.C.P.

University of Florida

Aidan Power, M.B.B.Ch., M.Sc.,

M.R.C Psych.

Pfizer Worldwide

Lori M. Reilly, Esq.

PhRMA

Wayne A. Rosenkrans, Jr., Ph.D.

(Past Chair PMC)

MIT (Ret.)

Jared N. Schwartz, M.D., Ph.D.

Leica Biosystems

Michael J. Vasconcelles, M.D.

Takeda Pharmaceuticals

International Company

SOURCE

http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/pmc_membership_brochure.pdf

Upcoming Events

• .
  October 21, 2014

  Better Science, Better Health: New Trial Pathways and Better Patient Data

  Event website »
• .
  October 27, 2014

  2014 | Medical Innovation Summit

  Now, it’s Personal
  Cancer Treatment and Personalized Medicine

  Event website »

• .
  October 29, 2014

  The 6th Annual Personalized & Precision Medicine Conference

  Event website »
• .
  November 06, 2014

  2014 Cancer Center Business Summit

  Read More »
• .
  November 11, 2014

  10th Annual Boston Reception

  Read More »
• .
  November 12, 2014

  10th Annual Personalized Medicine Conference

  Event website »
• .
  November 17, 2014

  The Third Annual Evidence-Based Reimbursement Summit

  Read More »
• .
  December 05, 2014

  12th Annual Dr. Roizen’s Personalized, Preventive, and Integrative Medicine Conference

  The Future of Healthcare with a Focus on Women’s Health

  Event website »

• .
  January 26, 2015

  Personalized Medicine World Conference 2015: Silicon Valley

  Read More »
• .
  March 17, 2015

  26th Annual Cancer Progress Conference

  Event website »

SOURCE

See more at: http://www.personalizedmedicinecoalition.org/Events#sthash.gSaNVC7A.dpuf